Solid Biosciences Inc.
SLDB
$6.57
$0.162.50%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -37.30% | -39.80% | -63.16% | -69.90% | -54.77% |
| Total Depreciation and Amortization | -35.94% | -33.36% | -23.99% | -28.65% | 13.63% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.93% | 19.82% | 126.08% | 302.27% | 208.09% |
| Change in Net Operating Assets | -184.15% | -339.37% | 577.99% | 223.87% | 169.31% |
| Cash from Operations | -60.93% | -56.27% | -45.17% | -43.61% | -16.74% |
| Capital Expenditure | -88.91% | -76.30% | -46.67% | 20.48% | 45.51% |
| Sale of Property, Plant, and Equipment | 1,600.00% | 1,600.00% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 435.53% | -271.74% | -649.85% | -44.35% | 93.17% |
| Cash from Investing | 372.13% | -263.38% | -614.98% | -41.77% | 92.34% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 3.29% | -52.85% | -87.83% | -133.33% | -- |
| Issuance of Common Stock | 25.77% | 53.76% | 63.49% | 69.82% | 78.70% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -4,655.23% | 67.11% | 67.11% | 67.11% | 93.66% |
| Cash from Financing | 18.94% | 58.81% | 69.17% | 75.90% | 85.68% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.89% | -420.19% | -119.65% | 887.92% | 297.97% |